G protein-coupled estrogen receptor agonist improves cerebral microvascular function after hypoxia/reoxygenation injury in male and female rats

Stroke

Volumn 44, Issue 3, 2013, Pages 779-785

  Murata, Takahiro ^a   Dietrich, Hans H ^a   Xiang, Chuanxi ^a   Dacey Jr , Ralph G ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Brain hypoxia; GPER protein; Recovery of function; Sex differences

Indexed keywords

ADENOSINE TRIPHOSPHATE; ARACHIDONIC ACID; CYTOKINE RECEPTOR AGONIST; G 1; G PROTEIN COUPLED RECEPTOR 30; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTERIOLE; ARTICLE; BLOOD VESSEL DIAMETER; BLOOD VESSEL REACTIVITY; BRAIN FUNCTION; BRAIN HYPOXIA; CANNULATION; CEREBRAL MICROVASCULAR FUNCTION; COMPUTER AIDED DESIGN; CONTROLLED STUDY; FEMALE; ISOLATION PROCEDURE; MALE; MICROSCOPY; NONHUMAN; PRIORITY JOURNAL; RAT; REPERFUSION INJURY; SEX DIFFERENCE; SMOOTH MUSCLE RELAXATION; VASODILATATION; VASOMOTOR REFLEX; VIDEOMICROSCOPY;

ANIMALS; BENZODIOXOLES; BRAIN; CEREBROVASCULAR CIRCULATION; CYCLOPENTANES; ESTROGENS; FEMALE; MALE; MICROVESSELS; MODELS, ANIMAL; QUINOLINES; RATS; RATS, INBRED LEW; RECEPTORS, G-PROTEIN-COUPLED; REPERFUSION INJURY; SEX FACTORS; SIGNAL TRANSDUCTION; VASODILATION;

EID: 84876284004     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.112.678177     Document Type: Article

References (33)

1. Hurn PD, Macrae IM. Estrogen as a neuroprotectant in stroke. J Cereb Blood Flow Metab. 2000;20:631-652.
2. McCullough LD, Alkayed NJ, Traystman RJ, Williams MJ, Hurn PD. Postischemic estrogen reduces hypoperfusion and secondary ischemia after experimental stroke. Stroke. 2001;32:796-802.
3. Luksha L, Kublickiene K. The role of estrogen receptor subtypes for vascular maintenance. Gynecol Endocrinol. 2009;25:82-95.
4. Simoncini T, Mannella P, Genazzani AR. Rapid estrogen actions in the cardiovascular system. Ann N Y Acad Sci. 2006;1089:424-430.
5. Haas E, Meyer MR, Schurr U, Bhattacharya I, Minotti R, Nguyen HH, et al. Differential effects of 17beta-estradiol on function and expression of estrogen receptor alpha, estrogen receptor beta, and GPR30 in arteries and veins of patients with atherosclerosis. Hypertension. 2007;49:1358-1363.
6. Clavier N, Kirsch JR, Hurn PD, Traystman RJ. Effect of postischemic hypoperfusion on vasodilatory mechanisms in cats. Am J Physiol. 1994;267(5 pt 2):H2012-H2018.
7. Mayhan WG, Amundsen SM, Faraci FM, Heistad DD. Responses of cerebral arteries after ischemia and reperfusion in cats. Am J Physiol. 1988;255(4 pt 2):H879-H884.
8. Cipolla MJ, Bullinger LV. Reactivity of brain parenchymal arterioles after ischemia and reperfusion. Microcirculation. 2008;15:495-501.
9. Bari F, Louis TM, Meng W, Busija DW. Global ischemia impairs ATPsensitive K+ channel function in cerebral arterioles in piglets. Stroke. 1996;27:1874-80; discussion 1880.
10. Hossmann KA. Pathophysiology and therapy of experimental stroke. Cell Mol Neurobiol. 2006;26:1057-1083.
11. Watanabe Y, Littleton-Kearney MT, Traystman RJ, Hurn PD. Estrogen restores postischemic pial microvascular dilation. Am J Physiol Heart Circ Physiol. 2001;281:H155-H160.
12. Stirone C, Duckles SP, Krause DN, Procaccio V. Estrogen increases mitochondrial efficiency and reduces oxidative stress in cerebral blood vessels. Mol Pharmacol. 2005;68:959-965.
13. Dacey RG Jr, Duling BR. A study of rat intracerebral arterioles: methods, morphology, and reactivity. Am J Physiol. 1982;243:H598-H606.
14. Horiuchi T, Dietrich HH, Tsugane S, Dacey RG Jr. Analysis of purineand pyrimidine-induced vascular responses in the isolated rat cerebral arteriole. Am J Physiol Heart Circ Physiol. 2001;280:H767-H776.
15. Dennis MK, Burai R, Ramesh C, Petrie WK, Alcon SN, Nayak TK, et al. In vivo effects of a GPR30 antagonist. Nat Chem Biol. 2009;5:421-427.
16. Lindsey SH, Carver KA, Prossnitz ER, Chappell MC. Vasodilation in response to the GPR30 agonist G-1 is not different from estradiol in the mRen2.Lewis female rat. J Cardiovasc Pharmacol. 2011;57:598-603.
17. Horiuchi T, Dietrich HH, Hongo K, Dacey RG Jr. Comparison of P2 receptor subtypes producing dilation in rat intracerebral arterioles. Stroke. 2003;34:1473-1478.
18. Broughton BR, Miller AA, Sobey CG. Endothelium-dependent relaxation by G protein-coupled receptor 30 agonists in rat carotid arteries. Am J Physiol Heart Circ Physiol. 2010;298:H1055-H1061.
19. Lindsey SH, Yamaleyeva LM, Brosnihan KB, Gallagher PE, Chappell MC. Estrogen receptor GPR30 reduces oxidative stress and proteinuria in the salt-sensitive female mRen2.Lewis rat. Hypertension. 2011;58:665-671.
20. Lindsey SH, Cohen JA, Brosnihan KB, Gallagher PE, Chappell MC. Chronic treatment with the G protein-coupled receptor 30 agonist G-1 decreases blood pressure in ovariectomized mRen2.Lewis rats. Endocrinology. 2009;150:3753-3758.
21. Deroo BJ, Korach KS. Estrogen receptors and human disease. J Clin Invest. 2006;116:561-570.
22. Knot HJ, Lounsbury KM, Brayden JE, Nelson MT. Gender differences in coronary artery diameter reflect changes in both endothelial Ca2+ and ecNOS activity. Am J Physiol. 1999;276(3 Pt 2):H961-H969.
23. Case J, Davison CA. Estrogen alters relative contributions of nitric oxide and cyclooxygenase products to endothelium-dependent vasodilation. J Pharmacol Exp Ther. 1999;291:524-530.
24. Orshal JM, Khalil RA. Gender, sex hormones, and vascular tone. Am J Physiol Regul Integr Comp Physiol. 2004;286:R233-R249.
25. Rahimian R, Chan L, Goel A, Poburko D, van Breemen C. Estrogen modulation of endothelium-derived relaxing factors by human endothelial cells. Biochem Biophys Res Commun. 2004;322:373-379.
26. Isensee J, Meoli L, Zazzu V, Nabzdyk C, Witt H, Soewarto D, et al. Expression pattern of G protein-coupled receptor 30 in LacZ reporter mice. Endocrinology. 2009;150:1722-1730.
27. Yu X, Ma H, Barman SA, Liu AT, Sellers M, Stallone JN, et al. Activation of G protein-coupled estrogen receptor induces endotheliumindependent relaxation of coronary artery smooth muscle. Am J Physiol Endocrinol Metab. 2011;301:E882-E888.
28. Lu T, He T, Katusic ZS, Lee HC. Molecular mechanisms mediating inhibition of human large conductance Ca2+-activated K+ channels by high glucose. Circ Res. 2006;99:607-616.
29. Ross J, Armstead WM. Differential role of PTK and ERK MAPK in superoxide impairment of K(ATP) and K(Ca) channel cerebrovasodilation. Am J Physiol Regul Integr Comp Physiol. 2003;285:R149-R154.
30. Pelligrino DA, Santizo R, Baughman VL, Wang Q. Cerebral vasodilating capacity during forebrain ischemia: effects of chronic estrogen depletion and repletion and the role of neuronal nitric oxide synthase. Neuroreport. 1998;9:3285-3291.
31. Hurn PD, Littleton-Kearney MT, Kirsch JR, Dharmarajan AM, Traystman RJ. Postischemic cerebral blood flow recovery in the female: effect of 17 beta-estradiol. J Cereb Blood Flow Metab. 1995;15: 666-672.
32. Dietrich HH, Horiuchi T, Xiang C, Hongo K, Falck JR, Dacey RG Jr. Mechanism of ATP-induced local and conducted vasomotor responses in isolated rat cerebral penetrating arterioles. J Vasc Res. 2009;46: 253-264.
33. Lebesgue D, Chevaleyre V, Zukin RS, Etgen AM. Estradiol rescues neurons from global ischemia-induced cell death: multiple cellular pathways of neuroprotection. Steroids. 2009;74:555-561.